Pregled bibliografske jedinice broj: 568569
Brief psychiatric rating scale and clinical global impression in evaluation of symptoms in schizophrenic patients taking typical and atypical antipsychotics
Brief psychiatric rating scale and clinical global impression in evaluation of symptoms in schizophrenic patients taking typical and atypical antipsychotics // Schizophrenia research 67 (1S) - Abstracts of the XIIth Biennal Winter Workshop on Schizophrenia / Crow, Timothy J. ; Hirsch, Steven R. (ur.).
Amsterdam: Elsevier, 2004. str. 151-152 (poster, međunarodna recenzija, sažetak, znanstveni)
CROSBI ID: 568569 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Brief psychiatric rating scale and clinical global impression in evaluation of symptoms in schizophrenic patients taking typical and atypical antipsychotics
(Brief psychiatric rating scale and clinical global impression in evaluation so symptoms in schizophrenic patients taking typical and atypical antipsychotics)
Autori
Uzun, Suzana ; Folnegović, Vera ; Mimica, Ninoslav ; Vilibić, Maja ; Kozumplik, Oliver
Vrsta, podvrsta i kategorija rada
Sažeci sa skupova, sažetak, znanstveni
Izvornik
Schizophrenia research 67 (1S) - Abstracts of the XIIth Biennal Winter Workshop on Schizophrenia
/ Crow, Timothy J. ; Hirsch, Steven R. - Amsterdam : Elsevier, 2004, 151-152
Skup
XIIth Biennal Winter Workshop on Schizophrenia
Mjesto i datum
Davos, Švicarska, 07.02.2004. - 13.02.2004
Vrsta sudjelovanja
Poster
Vrsta recenzije
Međunarodna recenzija
Ključne riječi
Brief psychiatric rating scale; Clinical global impression; Schizophrenia
Sažetak
Objective: To measure symptomatic improvement with the Brief Psychiatry Rating Scale (BPRS) and Clinical global impressions (CGI) in schizophrenic patients taking typical and atypical antipsychotics. Methods: BPRS and CGI were used in order to assess symptomatic improvement in 100 patients with paranoid schizophrenia, according to DSM-IV-TR criteria. First assessment was made upon the inclusion, the second assessment was made after 6 months of continuous treatment with typical or atypical antipsychotics. Results: At baseline there was no significant difference between two groups of patients, after 6 months of continuous treatment, patients treated with atypcal antipsychotics scored significantly better in BPRS items regarding emotional withdrawal, depressive mood, uncooperativeness and blunted affect. Conclusion: Results indicate superiority of atypical over typical antipsychotics in reducing negative and general symptoms of schizophrenia.
Izvorni jezik
Engleski
Znanstvena područja
Kliničke medicinske znanosti
POVEZANOST RADA
Ustanove:
Medicinski fakultet, Zagreb,
Klinika za psihijatriju Vrapče
Citiraj ovu publikaciju:
Časopis indeksira:
- Current Contents Connect (CCC)
- Web of Science Core Collection (WoSCC)
- Science Citation Index Expanded (SCI-EXP)
- Social Science Citation Index (SSCI)
- SCI-EXP, SSCI i/ili A&HCI
- Scopus
- MEDLINE